# Jasper Therapeutics, Inc.: Form DEF 14A, filed Dec 4, 2020

- Company: [Jasper Therapeutics, Inc.](/companies/jspr.md) (CIK 1788028)
- Form: DEF 14A
- Filed: 2020-12-04
- Accepted by EDGAR: Dec 4, 2020, 17:20 ET
- Period: 2020-12-22
- Accession: 0001213900-20-041132
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1788028/000121390020041132/def14a2020_amplitudehealth.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1788028/000121390020041132/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1788028/000121390020041132/def14a2020_amplitudehealth.htm

Filed Dec 4, 2020.
Source: SEC EDGAR, the filing index for accession 0001213900-20-041132. Last ingested by Listed: Nov 9, 2026, 17:50 ET. No prices; not investment advice.